Sign in

CIK 0001802768

  • Large accelerated filer

Royalty Pharma plc

Sign in to watch
Ticker
RPRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+1 212-883-0200
Business address
110 EAST 59TH STREET, NEW YORK, NY, 10022
  1. 4 Grant or award Director acquired 9,293 shares (grant or award)
  2. 4 Grant or award Director acquired 9,293 shares (grant or award)
  3. 4 Grant or award Director acquired 9,293 shares (grant or award)
  4. 4 Grant or award Director acquired 9,293 shares (grant or award)
  5. 4 Grant or award Director acquired 9,293 shares (grant or award)
  6. 4 Grant or award Director acquired 9,293 shares (grant or award)
  7. 4 Conversion EVP & Vice Chairman acquired 300,000 shares (conversion)
  8. 4 Grant or award Director acquired 1,240 shares (grant or award)
  9. 4 Grant or award Director acquired 1,240 shares (grant or award)
  10. 4 Conversion Director acquired 300,000 shares (conversion)
  11. 4 Planned sale Director sold 470,000 shares at an average $28.13 ($13,222,862)
  12. 4 Open-market sale 10% owner sold 65,803 shares at $28.04 ($1,845,406)
  13. 4 Grant or award Director acquired 1,353 shares (grant or award)
  14. 4 Grant or award Director acquired 1,353 shares (grant or award)
  15. 4 Open-market sale 10% owner sold 251,592 shares at an average $28.17 ($7,087,688)
  16. 4 Open-market sale 10% owner sold 10,229 shares at $28.01 ($286,499)
  17. 4 Open-market sale 10% owner sold 672,376 shares at an average $28.93 ($19,450,288)
  18. 4 Gift CEO, Chairman of the Board gave 292,190.49 shares (gift)
  19. 4 Conversion EVP, Investments & CLO acquired 150,000 shares (conversion)
  20. 4 Conversion Director acquired 475,590 shares (conversion)

Page 7 of 18 · 342 filings